@pbsnews: The Food and Drug Administration issued a new warning on Monday about the risk of vision loss related to popular GLP-1 weight loss and diabetes drugs. Health officials say drugs like Eli Lilly’s Zepbound and Ozempic by Novo Nordisk must add a warning label about the rare disease, which can cause blurred vision or blindness. The FDA says anyone experiencing such problems should contact a health care professional immediately. While the condition is permanent with no known treatment, experts say it occurs in only a tiny fraction of patients. #glp1 #fda #diabetes #health#medicine #visionloss #patients #pbsnews #pbs #pbsnewshour

pbsnews

Open In TikTok:

Region: US

Tuesday 10 November 2026 16:30:00 GMT